Trials / Completed
CompletedNCT04258865
A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348
Phase I Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 With Co-administration of CKD-828, D097 and D337 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A clinical trial to compare the pharmacokinetics and tolerability of CKD-348
Detailed description
A randomized, open-label, single-dose, 3-way crossover clinical trial to compare the pharmacokinetics and tolerability of CKD-348 with co-administrated drugs in healthy adult volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-348 F1 | QD, PO |
| DRUG | CKD-348 F2 | QD, PO |
| DRUG | CKD-828, D097, D337 | QD, PO |
Timeline
- Start date
- 2020-03-25
- Primary completion
- 2020-04-26
- Completion
- 2020-05-13
- First posted
- 2020-02-06
- Last updated
- 2020-06-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04258865. Inclusion in this directory is not an endorsement.